Related Experiment Videos
[A clinical observation of cefuroxime in pediatric field (author's transl)]
The Japanese Journal of Antibiotics
|November 1, 1979
Insights
Cefuroxime effectively treated pediatric infections, including respiratory and urinary tract infections, sepsis, and enterocolitis. All patients experienced good to excellent clinical outcomes with no observed side effects.
Area of Science:
- Pediatric infectious diseases
- Pharmacology of cephalosporins
- Clinical microbiology
Background:
- Cefuroxime is a novel synthetic cephalosporin antibiotic.
- Pediatric infections pose significant health challenges.
- Evaluating new antibiotic efficacy in pediatric populations is crucial.
Observation:
- Ten pediatric patients with various infections were treated with cefuroxime.
- Infections included respiratory tract infections, urinary tract infections, E. coli sepsis, and enterocolitis.
- Treatment outcomes and adverse events were closely monitored.
Findings:
- Cefuroxime demonstrated high clinical efficacy across all treated pediatric patients.
- All ten cases achieved good to excellent clinical results.
- No adverse side effects were reported during the treatment course.
Implications:
- Cefuroxime presents a promising therapeutic option for pediatric infectious diseases.
- The safety profile suggests good tolerability in the pediatric population.
- Further research may support broader clinical application of cefuroxime in children.
Abstract:
Cefuroxime, a new synthetic cephalosporin, was administered to 10 pediatric patients (6 with respiratory tract infection, 2 with urinary tract infection, 1 with sepsis of E. coli and 1 with enterocolitis). The clinical result was good and excellent in all the 10 cases. No side effect was observed in any of them.